Quality of adjuvant CMF chemotherapy for node-positive primary breast cancer: a population-based study

By Schaapveld Michael   Vries Elisabeth   Graaf Winette   Otter Renée   Willemse Pax  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 10, 2004-10 ,pp. : 581-590

Springer Publishing Company

Access to resources Recommend Favorite

Quality of life after adjuvant chemotherapy for breast cancer

By Broeckel J.A.   Jacobsen P.B.   Balducci L.   Horton J.   Lyman G.H.  

Breast Cancer Research and Treatment, Vol. 62, Iss. 2, 2000-07 ,pp. : 141-150

Springer Publishing Company

Access to resources Recommend Favorite

Acute and Late Toxicity Following Adjuvant High-Dose Chemotherapy for High-Risk Primary Operable Breast Cancer A Quality Assessment Study

By Svane Inge M.   Homburg Keld M.   Kamby Claus   Nielsen Dorte L.   Roer Ole   Sliffsgaard Dorte   Johnsen Hans E.   Hansen Steen W.  

Acta Oncologica, Vol. 41, Iss. 7-8, 2002-11 ,pp. : 675-683

Informa Healthcare

Access to resources Recommend Favorite

Acute toxicity of concurrent adjuvant radiotherapy and chemotherapy (CMF or AC) in breast cancer patients - a prospective, comparative, non-randomised study

By Fiets W.E.   van Helvoirt R.P.   Nortier J.W.R.   van der Tweel I.   Struikmans H.  

European Journal of Cancer, Vol. 39, Iss. 8, 2003-05 ,pp. : 1081-1088

Elsevier

Access to resources Recommend Favorite

Outcomes following local therapy for early-stage breast cancer in non-trial populations

By Keating Nancy  

Breast Cancer Research and Treatment, Vol. 125, Iss. 3, 2011-02 ,pp. : 803-813

Springer Publishing Company

Access to resources Recommend Favorite